Evidence map›Paper›PMID 29372907›Full record

ArticleActa crystallographica. Section F, Structural biology communications2018

Solution NMR structures of oxidized and reduced Ehrlichia chaffeensis thioredoxin: NMR-invisible structure owing to backbone dynamics.

Garry W Buchko, Stephen N Hewitt, Wesley C Van Voorhis, Peter J Myler

Open access · bronzeAbstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Garry W BuchkoSeattle Structural Genomics Center for Infectious Disease, USA.ORCID 0000-0002-3639-1061
Stephen N HewittSeattle Structural Genomics Center for Infectious Disease, USA.
Wesley C Van VoorhisSeattle Structural Genomics Center for Infectious Disease, USA.
Peter J MylerSeattle Structural Genomics Center for Infectious Disease, USA.ORCID 0000-0002-0056-0513
University of Washington · USCenter for Infectious Disease Research · USPacific Northwest National Laboratory · US

Funding

National Institute of Allergy and Infectious Diseases HHSN2722001200025CNIAID NIH HHS HHSN272200700057CNIAID NIH HHS HHSN272201200025C
6 · The paper itself

Abstract

Thioredoxins are small ubiquitous proteins that participate in a diverse variety of redox reactions via the reversible oxidation of two cysteine thiol groups in a structurally conserved active site. Here, the NMR solution structures of a reduced and oxidized thioredoxin from Ehrlichia chaffeensis (Ec-Trx, ECH_0218), the etiological agent responsible for human monocytic ehrlichiosis, are described. The overall topology of the calculated structures is similar in both redox states and is similar to those of other thioredoxins: a five-stranded, mixed β-sheet (β1-β3-β2-β4-β5) surrounded by four α-helices. Unlike other thioredoxins studied by NMR in both redox states, the

Indexed as

Amino Acid SequenceBacterial ProteinsCircular DichroismConserved SequenceEhrlichia chaffeensisHumansModels, MolecularNuclear Magnetic Resonance, BiomolecularOxidation-ReductionProlineProtein StabilityRecombinant ProteinsSequence Homology, Amino AcidSolutionsThermodynamicsThioredoxinsBacterial ProteinsProlineRecombinant ProteinsSolutionsThioredoxinsEhrlichia chaffeensishuman monocytic ehrlichiosisinfectious diseasesmolecular dynamicsNMRreactive oxygen speciesstructural biologythioredoxin

Identifiers

PMID29372907
PMCPMC5947692
OpenAlexW2776025403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.